AI
Friday, May 05, 2023 1:41:33 PM
HyGro,
I think Ray Tancredi would disagree with you. He has served as the divisional vice president at Walgreens for well over a decade and has studied the clinical pipeline to FDA approval for years.
https://naspnet.org/leadership/ray-tancredi-rph-mba-csp
Mr. Tancredi compiled an interesting list of pipeline drugs to watch in 2023. His list and commentary were recently published in the news section of the website for The American Journal of Managed Care®:
https://www.ajmc.com/view/an-overview-of-the-specialty-therapy-pipeline-in-2023
I think Ray Tancredi would disagree with you. He has served as the divisional vice president at Walgreens for well over a decade and has studied the clinical pipeline to FDA approval for years.
https://naspnet.org/leadership/ray-tancredi-rph-mba-csp
Mr. Tancredi compiled an interesting list of pipeline drugs to watch in 2023. His list and commentary were recently published in the news section of the website for The American Journal of Managed Care®:
https://www.ajmc.com/view/an-overview-of-the-specialty-therapy-pipeline-in-2023
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
